Clinical Trial Update: Study of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This ClinicalTrials.gov update announces a Phase 1 study of IBI3009 in participants with unresectable, metastatic or extensive-stage small cell lung cancer. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• IBI3009

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Small Cell Lung Cancer | Phase 1 | Status: RECRUITING